Blue Owl's Co-CEOs, Doug Ostrover and Marc Lipschultz, are confident in the company's business model and growth potential. They emphasized the firm's strong expansion across all sectors and the creation of new capital solutions for emerging markets.
The economic outcome might determine private debt success. If a soft landing isn't achieved, companies could sustain unviable businesses, resembling Ponzi schemes. Only 46% of such could remain cash flow positive under mild stress, says S&P Global Ratings.
Blue Owl Capital's high price-to-sales ratio may be warranted given its robust revenue growth and bright outlook. If revenue growth continues to surpass industry average, investors may find comfort in the high P/S ratio, anticipating steady near-term share prices.
Blue Owl's Co-CEOs express confidence in their resilient business model, poised to benefit from investors' demand for differentiated products, predictable income, and downside protection. They highlight the company's remarkable growth and global potential.
Blue Owl Capital Stock Forum
How Wingspire's Latest $30M Deal Signals Growing Dominance in Tech Financing Market
How Wingspire's Latest $30M Deal Signals Growing Dominance in Tech Financing Market
lets see what happens after earnings🙏🏾
• $Revlon (REV.US)$ +81% (Reliance mulling buyout of REV according to Economic Times)
• $United States Steel (X.US)$ +6.4% (issues upside EPS guidance),
• $Ellington Financial (EFC.US)$ +5% (reports book value per share)
• $Aurora Mobile (JG.US)$ +4.9% (receives RMB15 mln in special support funding from the Shenzhen Development and Reform Commission)
• $Citi Trends (CTRN.US)$ +4.4% (names new CFO)
• $Roku Inc (ROKU.US)$ +4.2% (ROKU an...
• $Seres Therapeutics (MCRB.US)$ : Jefferies Upgrades to Buy from Hold
• $Ferrari (RACE.US)$ : Kepler Upgrades to Hold from Reduce
Downgrades
• $Dutch Bros (BROS.US)$ : JPMorgan Downgrades to Neutral from Overweight - PT $40
• $Canopy Growth (CGC.US)$ : BMO Capital Downgrades to Underperform from Market Perform - PT Cdn$2.50 (from Cdn$6)
• $Cazoo (CZOO.US)$ : Citigroup Downgrades to Neutral from Buy - PT $1.50 (from $9)
• $Chart Industries (GTLS.US)$ : Barcla...
• $Repare Therapeutics (RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy (CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath (PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage (PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology (CRDO.US)$ +10.2% (In reaction ...
No comment yet